Lv2
142 积分 2023-07-16 加入
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
2个月前
已完结
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
3个月前
已完结
Transposable Elements: An Abundant and Natural Source of Regulatory Sequences for Host Genes
4个月前
已完结
Regulatory evolution of innate immunity through co-option of endogenous retroviruses
4个月前
已完结
The implications of IDH mutations for cancer development and therapy
4个月前
已完结
PKN2 is a dependency of the mesenchymal-like cancer cell state
4个月前
已完结
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
4个月前
已完结
Development and therapeutic potential of DNA-dependent protein kinase inhibitors
5个月前
已完结
58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study
5个月前
已关闭
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
5个月前
已完结
皖公网安备34019202002308
